Baraki, Hassina

[["dc.bibliographiccitation.firstpage","107"],["dc.bibliographiccitation.issue","02"],["dc.bibliographiccitation.journal","The Thoracic and Cardiovascular Surgeon"],["dc.bibliographiccitation.lastpage","113"],["dc.bibliographiccitation.volume","68"],["dc.contributor.author","Saha, Shekhar"],["dc.contributor.author","Varghese, Sam"],["dc.contributor.author","Ahmad, Ammar Al"],["dc.contributor.author","Jebran, Ahmad Fawad"],["dc.contributor.author","Waezi, Narges"],["dc.contributor.author","Niehaus, Heidi"],["dc.contributor.author","Baraki, Hassina"],["dc.contributor.author","Kutschka, Ingo"],["dc.date.accessioned","2020-12-10T18:12:17Z"],["dc.date.available","2020-12-10T18:12:17Z"],["dc.date.issued","2020"],["dc.identifier.doi","10.1055/s-0038-1670663"],["dc.identifier.eissn","1439-1902"],["dc.identifier.issn","0171-6425"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/74313"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Complex Valve Surgery in Elderly Patients: Increasingly Necessary and Surprisingly Feasible"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","590"],["dc.bibliographiccitation.issue","7"],["dc.bibliographiccitation.journal","Perfusion"],["dc.bibliographiccitation.lastpage","597"],["dc.bibliographiccitation.volume","34"],["dc.contributor.author","Saha, Shekhar"],["dc.contributor.author","Varghese, Sam"],["dc.contributor.author","Herr, Mike"],["dc.contributor.author","Leistner, Marcus"],["dc.contributor.author","Ulrich, Christian"],["dc.contributor.author","Niehaus, Heidi"],["dc.contributor.author","Ahmad, Ammar Al"],["dc.contributor.author","Baraki, Hassina"],["dc.contributor.author","Kutschka, Ingo"],["dc.date.accessioned","2020-12-10T18:38:24Z"],["dc.date.available","2020-12-10T18:38:24Z"],["dc.date.issued","2019"],["dc.description.abstract","Objectives: Minimally invasive extracorporeal circulation circuits provide several advantages compared to conventional extracorporeal circulation circuits. We compared the results of a minimally invasive extracorporeal circulation system with those of conventional extracorporeal circulation system, in patients undergoing isolated coronary artery bypass grafting. Methods: We identified 753 consecutive patients who underwent coronary artery bypass grafting at our centre between October 2014 and September 2016. These patients were divided into two groups: a minimally invasive extracorporeal circulation group (M, n = 229) and a conventional extracorporeal circulation group (C, n = 524). Baseline parameters, details of cardiac surgery as well as postoperative complications and outcomes were compared by means of a propensity-matched analysis of 180 matched pairs. Results: The median EuroSCORE II was 1.3%. Transfusion requirement of packed red blood cells (p = 0.002) was lower in Group M compared to conventional extracorporeal circulation systems. There were no differences in hospital mortality or in rates of adverse events between the matched groups. Total in-hospital mortality of the cohort was 1.7%. Conclusion: The use of minimally invasive extracorporeal circulation is associated with a significantly lower use of blood products after isolated coronary revascularisation. There were no differences concerning duration of surgery, complication rates and mortality between the groups. Therefore, the application of minimally invasive extracorporeal circulation systems should be considered as preferred technique in isolated coronary artery bypass grafting procedures."],["dc.identifier.doi","10.1177/0267659119842060"],["dc.identifier.eissn","1477-111X"],["dc.identifier.issn","0267-6591"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77306"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.publisher","SAGE Publications"],["dc.relation.eissn","1477-111X"],["dc.relation.issn","0267-6591"],["dc.title","Minimally invasive versus conventional extracorporeal circulation circuits in patients undergoing coronary artery bypass surgery: a propensity-matched analysis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","850"],["dc.bibliographiccitation.issue","11"],["dc.bibliographiccitation.journal","Journal of Tissue Engineering and Regenerative Medicine"],["dc.bibliographiccitation.lastpage","861"],["dc.bibliographiccitation.volume","8"],["dc.contributor.author","Minol, Jan-Philipp"],["dc.contributor.author","Baraki, Hassina"],["dc.contributor.author","Akhyari, Payam"],["dc.contributor.author","Bagaev, Eric"],["dc.contributor.author","Suprunov, Marc"],["dc.contributor.author","Brandes, Gudrun"],["dc.contributor.author","Bara, Christoph L."],["dc.contributor.author","Hort, Waldemar"],["dc.contributor.author","Hurschler, Christof"],["dc.contributor.author","Sigler, Matthias"],["dc.contributor.author","Haverich, Axel"],["dc.contributor.author","Hilfiker, Andres"],["dc.contributor.author","Lichtenberg, Artur"],["dc.date.accessioned","2018-11-07T09:33:10Z"],["dc.date.available","2018-11-07T09:33:10Z"],["dc.date.issued","2014"],["dc.description.abstract","Modern cardiovascular medicine aims for procedures that preferably involve biological materials and, ideally, living implants. Thereby, the regenerative capacity of the target organ may be preserved or even supported, with a potential implant growth capacity during the following time. In the current study we sought to evaluate the integrative capacity of vital and non-vital tracheal cartilage rings (TCRs) of allogenic or xenogenic origin (allo-/xeno-vTCR; allo-/xeno-nvTCR) as biomaterials under the in vivo functional load of the circulatory system. Ovine and porcine vTCRs and nvTCRs were implanted in the mitral valve (MV) position for 3 and 9 months (n=3 each), respectively, in lambs. MV function and TCR position were analysed by echocardiography. Tissue morphology (planimetry), vitality (live/dead-assay) and implant endothelialization (scanning electron microscopy) were analysed. No functional impairment or significant MV insufficiency or stenosis was observed in any group. TCR shrinkage was observed in all xeno-TCRs and allo-nvTCRs at 3 months. Only TCRs of allogenic groups at 9 months and allo-vTCRs at 3 months showed a ring area comparable to its size at implantation. Moreover, allogenic vital cartilage showed superior tissue integration, greater endothelialization, less inflammation and calcification. Interestingly, in this group viable cartilage cells were found up to 9 months after implantation. Allogenic viable cartilage may represent a well-suited living material for reconstructive cardiovascular procedures, and further studies are warranted to elucidate the benefits of this novel material, particularly as a structurally supportive component in growing recipients. Copyright (c) 2012 John Wiley & Sons, Ltd."],["dc.description.sponsorship","Braukmann-Wittenberg Foundation, Lower Saxony, Germany"],["dc.identifier.doi","10.1002/term.1585"],["dc.identifier.isi","000344335700002"],["dc.identifier.pmid","22837178"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/31908"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.relation.issn","1932-7005"],["dc.relation.issn","1932-6254"],["dc.title","Tracheal cartilage - evaluating the potential of a novel biomaterial for reconstructive cardiovascular procedures"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","e0192652"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","PLOS ONE"],["dc.bibliographiccitation.volume","13"],["dc.contributor.author","Dahlmann, Julia"],["dc.contributor.author","Awad, George"],["dc.contributor.author","Dolny, Carsten"],["dc.contributor.author","Weinert, Sönke"],["dc.contributor.author","Richter, Karin"],["dc.contributor.author","Fischer, Klaus-Dieter"],["dc.contributor.author","Munsch, Thomas"],["dc.contributor.author","Leßmann, Volkmar"],["dc.contributor.author","Volleth, Marianne"],["dc.contributor.author","Zenker, Martin"],["dc.contributor.author","Chen, Yaoyao"],["dc.contributor.author","Merkl, Claudia"],["dc.contributor.author","Schnieke, Angelika"],["dc.contributor.author","Baraki, Hassina"],["dc.contributor.author","Kutschka, Ingo"],["dc.contributor.author","Kensah, George"],["dc.date.accessioned","2019-07-09T11:45:08Z"],["dc.date.available","2019-07-09T11:45:08Z"],["dc.date.issued","2018"],["dc.description.abstract","The possibility to generate cardiomyocytes from pluripotent stem cells in vitro has enormous significance for basic research, disease modeling, drug development and heart repair. The concept of heart muscle reconstruction has been studied and optimized in the rat model using rat primary cardiovascular cells or xenogeneic pluripotent stem cell derived-cardiomyocytes for years. However, the lack of rat pluripotent stem cells (rPSCs) and their cardiovascular derivatives prevented the establishment of an authentic clinically relevant syngeneic or allogeneic rat heart regeneration model. In this study, we comparatively explored the potential of recently available rat embryonic stem cells (rESCs) and induced pluripotent stem cells (riPSCs) as a source for cardiomyocytes (CMs). We developed feeder cell-free culture conditions facilitating the expansion of undifferentiated rPSCs and initiated cardiac differentiation by embryoid body (EB)-formation in agarose microwell arrays, which substituted the robust but labor-intensive hanging drop (HD) method. Ascorbic acid was identified as an efficient enhancer of cardiac differentiation in both rPSC types by significantly increasing the number of beating EBs (3.6 ± 1.6-fold for rESCs and 17.6 ± 3.2-fold for riPSCs). These optimizations resulted in a differentiation efficiency of up to 20% cTnTpos rPSC-derived CMs. CMs showed spontaneous contractions, expressed cardiac markers and had typical morphological features. Electrophysiology of riPSC-CMs revealed different cardiac subtypes and physiological responses to cardio-active drugs. In conclusion, we describe rPSCs as a robust source of CMs, which is a prerequisite for detailed preclinical studies of myocardial reconstruction in a physiologically and immunologically relevant small animal model."],["dc.identifier.doi","10.1371/journal.pone.0192652"],["dc.identifier.pmid","29513687"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/15042"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/59166"],["dc.language.iso","en"],["dc.notes.intern","Merged from goescholar"],["dc.relation","info:eu-repo/grantAgreement/EC/FP7/241504/EU//EURATRANS"],["dc.relation.issn","1932-6203"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.subject.ddc","610"],["dc.title","Generation of functional cardiomyocytes from rat embryonic and induced pluripotent stem cells using feeder-free expansion and differentiation in suspension culture."],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","4603"],["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","Anticancer Research"],["dc.bibliographiccitation.lastpage","4612"],["dc.bibliographiccitation.volume","39"],["dc.contributor.author","BUENTZEL, JUDITH"],["dc.contributor.author","HEINZ, JUDITH"],["dc.contributor.author","BLECKMANN, ANNALEN"],["dc.contributor.author","BAUER, CHRISTOPH"],["dc.contributor.author","RÖVER, CHRISTIAN"],["dc.contributor.author","BOHNENBERGER, HANIBAL"],["dc.contributor.author","SAHA, SHEKHAR"],["dc.contributor.author","HINTERTHANER, MARC"],["dc.contributor.author","BARAKI, HASSINA"],["dc.contributor.author","KUTSCHKA, INGO"],["dc.contributor.author","EMMERT, ALEXANDER"],["dc.date.accessioned","2020-12-10T18:43:04Z"],["dc.date.available","2020-12-10T18:43:04Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.21873/anticanres.13640"],["dc.identifier.eissn","1791-7530"],["dc.identifier.issn","0250-7005"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/78183"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Sarcopenia as Prognostic Factor in Lung Cancer Patients: A Systematic Review and Meta-analysis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Circulation Research"],["dc.bibliographiccitation.volume","128"],["dc.contributor.author","Kyryachenko, Sergiy"],["dc.contributor.author","Georges, Adrien"],["dc.contributor.author","Yu, Mengyao"],["dc.contributor.author","Barrandou, Takiy"],["dc.contributor.author","Guo, Lilong"],["dc.contributor.author","Bruneval, Patrick"],["dc.contributor.author","Rubio, Tony"],["dc.contributor.author","Gronwald, Judith"],["dc.contributor.author","Baraki, Hassina"],["dc.contributor.author","Bouatia-Naji, Nabila"],["dc.date.accessioned","2021-06-01T09:42:11Z"],["dc.date.available","2021-06-01T09:42:11Z"],["dc.date.issued","2021"],["dc.description.abstract","Rationale: Mitral valve prolapse (MVP) is a common valvopathy that leads to mitral insufficiency, heart failure, and sudden death. Functional genomic studies in mitral valves are needed to better characterize MVP-associated variants and target genes. Objective: To establish the chromatin accessibility profiles and assess functionality of variants and narrow down target genes at MVP loci. Methods and Results: We mapped the open chromatin regions in nuclei from 11 human pathogenic and 7 nonpathogenic mitral valves by an assay for transposase-accessible chromatin with high-throughput sequencing. Open chromatin peaks were globally similar between pathogenic and nonpathogenic valves. Compared with the heart tissue and cardiac fibroblasts, we found that MV-specific assay for transposase-accessible chromatin with high-throughput sequencing peaks are enriched near genes involved in extracellular matrix organization, chondrocyte differentiation, and connective tissue development. One of the most enriched motifs in MV-specific open chromatin peaks was for the nuclear factor of activated T cells family of TFs (transcription factors) involved in valve endocardial and interstitial cell formation. We also found that MVP-associated variants were significantly enriched ( P <0.05) in mitral valve open chromatin peaks. Integration of the assay for transposase-accessible chromatin with high-throughput sequencing data with risk loci, extensive functional annotation, and gene reporter assay suggest plausible causal variants for rs2641440 at the SMG6/SRR locus and rs6723013 at the IGFBP2/IGFBP5/TNS1 locus. CRISPR-Cas9 deletion of the sequence including rs6723013 in human fibroblasts correlated with increased expression only for TNS1 . Circular chromatin conformation capture followed by high-throughput sequencing experiments provided evidence for several target genes, including SRR , HIC1 , and DPH1 at the SMG6/SRR locus and further supported TNS1 as the most likely target gene on chromosome 2. Conclusions: Here, we describe unprecedented genome-wide open chromatin profiles from human pathogenic and nonpathogenic MVs and report specific gene regulation profiles, compared with the heart. We also report in vitro functional evidence for potential causal variants and target genes at MVP risk loci involving established and new biological mechanisms. Graphic Abstract: A graphic abstract is available for this article."],["dc.identifier.doi","10.1161/CIRCRESAHA.120.317581"],["dc.identifier.pmid","33508947"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/85168"],["dc.identifier.url","https://mbexc.uni-goettingen.de/literature/publications/301"],["dc.identifier.url","https://sfb1002.med.uni-goettingen.de/production/literature/publications/395"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-425"],["dc.relation","EXC 2067: Multiscale Bioimaging"],["dc.relation","SFB 1002: Modulatorische Einheiten bei Herzinsuffizienz"],["dc.relation","SFB 1002 | A13: Bedeutung einer gestörten zytosolischen Calciumpufferung bei der atrialen Arrhythmogenese bei Patienten mit Herzinsuffizienz (HF)"],["dc.relation.eissn","1524-4571"],["dc.relation.issn","0009-7330"],["dc.relation.workinggroup","RG Voigt (Molecular Pharmacology)"],["dc.title","Chromatin Accessibility of Human Mitral Valves and Functional Assessment of MVP Risk Loci"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","86"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Herz"],["dc.bibliographiccitation.lastpage","94"],["dc.bibliographiccitation.volume","45"],["dc.contributor.author","Hadem, J."],["dc.contributor.author","Rossnick, R."],["dc.contributor.author","Hesse, B."],["dc.contributor.author","Herr, M."],["dc.contributor.author","Hansen, M."],["dc.contributor.author","Bergmann, A."],["dc.contributor.author","Kensah, G."],["dc.contributor.author","Maess, C."],["dc.contributor.author","Baraki, H."],["dc.contributor.author","Kümpers, P."],["dc.contributor.author","Lukasz, A."],["dc.contributor.author","Kutschka, I."],["dc.date.accessioned","2020-12-10T14:07:55Z"],["dc.date.available","2020-12-10T14:07:55Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1007/s00059-018-4708-0"],["dc.identifier.eissn","1615-6692"],["dc.identifier.issn","0340-9937"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/70333"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Endotheliale Dysfunktion nach koronarer Bypass-Operation"],["dc.title.alternative","Endothelial dysfunction following coronary artery bypass grafting. Influence of patient and procedural factors"],["dc.title.subtitle","Einfluss von Patientenfaktoren und Operationstechnik"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","409"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Interactive Cardiovascular and Thoracic Surgery"],["dc.bibliographiccitation.lastpage","415"],["dc.bibliographiccitation.volume","29"],["dc.contributor.author","Jebran, Ahmad-Fawad"],["dc.contributor.author","Saha, Shekhar"],["dc.contributor.author","Waezi, Narges"],["dc.contributor.author","Al-Ahmad, Ammar"],["dc.contributor.author","Niehaus, Heidi"],["dc.contributor.author","Danner, Bernhard C."],["dc.contributor.author","Baraki, Hassina"],["dc.contributor.author","Kutschka, Ingo"],["dc.date.accessioned","2020-12-10T18:19:16Z"],["dc.date.available","2020-12-10T18:19:16Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1093/icvts/ivz112"],["dc.identifier.eissn","1569-9285"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/75185"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Design and training effects of a physical reality simulator for minimally invasive mitral valve surgery"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","4"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Journal of Cardiothoracic Surgery"],["dc.bibliographiccitation.volume","16"],["dc.contributor.author","Wittlinger, Thomas"],["dc.contributor.author","Maus, Martin"],["dc.contributor.author","Kutschka, Ingo"],["dc.contributor.author","Baraki, Hassina"],["dc.contributor.author","Friedrich, Martin G."],["dc.date.accessioned","2021-04-14T08:29:56Z"],["dc.date.accessioned","2022-08-18T12:40:00Z"],["dc.date.available","2021-04-14T08:29:56Z"],["dc.date.available","2022-08-18T12:40:00Z"],["dc.date.issued","2021-01-06"],["dc.date.updated","2022-07-29T12:17:46Z"],["dc.description.abstract","Abstract\r\n \r\n Background\r\n Acute kidney injury (AKI) is a frequent and serious complication of cardiac surgery, associated with a high incidence of morbidity and mortality. Although the RIFLE criteria serve as a prominent tool to identify patients at high risk of AKI, an optimized diagnosis model in clinical practice is desired.\r\n \r\n \r\n Methods\r\n Based on the SOP-criteria, 365 patients (10%) developed AKI following surgery and were subjected to RRT. In contrast, the incidence of AKI, defined according to the RIFLE criteria, was only 7% (n = 251 patients). Prominent risk factors identified by SOP were patients’ sex, valve and combined valve and bypass surgery, deep hypothermia, use of intra-aortic balloon pump (IABP) and previous coronary interventions. Ischemia, reperfusion, blood loss and surgery time also served as significant risk factors for patient evaluated by SOP.\r\n \r\n \r\n Results\r\n Risk assessment by RIFLE differed in as much as most patients with normothermia and those receiving only cardiovascular bypass developed AKI. However, patients’ sex and valve surgery did not serve as a risk factor.\r\n \r\n \r\n Conclusion\r\n Evaluation of patients by the RIFLE versus SOP criteria yielded different results with more AKI patients detected by SOP. Based on the present data, it is concluded that patients may not prone to AKI when surgery and ischemia time will be kept short, when blood loss is mitigated to a minimum and when surgery is performed under non-hypothermic conditions."],["dc.identifier.citation","Journal of Cardiothoracic Surgery. 2021 Jan 06;16(1):4"],["dc.identifier.doi","10.1186/s13019-020-01382-x"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/17720"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/83039"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/112976"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.notes.intern","Merged from goescholar"],["dc.publisher","BioMed Central"],["dc.relation.eissn","1749-8090"],["dc.rights","CC BY 4.0"],["dc.rights.holder","The Author(s)"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.subject","Acute kidney injury"],["dc.subject","Extracorporeal circulation"],["dc.subject","RIFLE classification"],["dc.subject","Continuous veno-venous hemodialysis"],["dc.subject","Cardiac surgery"],["dc.title","Risk assessment of acute kidney injury following cardiopulmonary bypass"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","975"],["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","Biomarkers in Medicine"],["dc.bibliographiccitation.lastpage","985"],["dc.bibliographiccitation.volume","12"],["dc.contributor.author","Albert, Christian"],["dc.contributor.author","Albert, Annemarie"],["dc.contributor.author","Bellomo, Rinaldo"],["dc.contributor.author","Kropf, Siegfried"],["dc.contributor.author","Devarajan, Prasad"],["dc.contributor.author","Westphal, Sabine"],["dc.contributor.author","Baraki, Hassina"],["dc.contributor.author","Kutschka, Ingo"],["dc.contributor.author","Butter, Christian"],["dc.contributor.author","Haase, Michael"],["dc.contributor.author","Haase-Fielitz, Anja"],["dc.date.accessioned","2020-12-10T18:43:38Z"],["dc.date.available","2020-12-10T18:43:38Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.2217/bmm-2018-0071"],["dc.identifier.eissn","1752-0371"],["dc.identifier.issn","1752-0363"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/78200"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Urinary neutrophil gelatinase-associated lipocalin-guided risk assessment for major adverse kidney events after open-heart surgery"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]